Feyza Aricioglu

Prof. Feyza Aricioglu


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2016 in Basic & Clinical Pharmacology & Toxicology
Verified
Journal Article
Closed access
PDF file
CSCeren Sahin
Ceren Sahin
OAOzgur Albayrak
Ozgur Albayrak
TATuğba F. Akdeniz
Tuğba F. Akdeniz
ZAZeynep Akbulut
Zeynep Akbulut
GDGULDEREN Yanikkaya YANIKKAYA DEMIREL
GULDEREN Yanikkaya YANIKKAYA DEMIREL
FAFeyza Aricioglu
Feyza Aricioglu

1 January 2012 in Behavioral and Brain Functions
Verified
Journal Article
Open access
PDF file
AKAyşe Karson
Ayşe Karson
TUTijen Utkan
Tijen Utkan
FBFuat Balci
Fuat Balci
FAFeyza Aricioglu
Feyza Aricioglu
NANurbay Ateş
Nurbay Ateş
Recent clinical studies revealed emotional and cognitive impairments associated with absence epilepsy. Preclinical research with genetic models of absence epilepsy however have primarily focused on dysfunctional emotional processes and paid relatively less attention to cognitive impairment. In order to bridge this gap, we investigated age-dependent changes in learning and memory performance, anxiety-like behavior, and locomotor activity of WAG/Rij rats (a valid model of generalized absence epilepsy) using passive avoidance, Morris water maze, elevated plus maze, and locomotor activity cage. We tested 5 month-old and 13 month-old WAG/Rij rats and compared their performance to age-matched Wistar rats. Results revealed a decline in emotional and spatial memory of WAG/Rij rats compared to age-matched Wistar rats only at 13 months of age. Importantly, there were no significant differences between WAG/Rij and Wistar rats in terms of anxiety-like behavior and locomotor activity at either age. Results pointed at age-dependent learning and memory deficits in the WAG/Rij rat model of absence epilepsy.

1 December 2019 in Brain Research
Verified
Journal Article
Closed access
COCeren Sahin Ozkartal
Ceren Sahin Ozkartal
ETErdem Tuzun
Erdem Tuzun
CKCem Ismail Kucukali
Cem Ismail Kucukali
CUCanan Ulusoy
Canan Ulusoy
MGMurat Giris
Murat Giris
FAFeyza Aricioglu
Feyza Aricioglu

6 January 2023 in Journal of Affective Disorders Reports
Verified
Journal Article
Open access
BLBrian E. Leonard
Brian E. Leonard
FAFeyza Aricioglu
Feyza Aricioglu

15 April 2020 in Psychiatry Investigation
Verified
Journal Article
Open access
PDF file
FAFeyza Aricioglu
Feyza Aricioglu
CYCanan Yalcinkaya
Canan Yalcinkaya
COCeren Sahin Ozkartal
Ceren Sahin Ozkartal
ETErdem Tüzün
Erdem Tüzün
SSSerap Sirvanci
Serap Sirvanci
TUTijen Utkan
Tijen Utkan
Objective NOD-like receptor protein 1 (NLRP1) inflammasome complex has been recently associated with chronic unpredictable mild stress (CUMS) model of depression. Our aim was to investigate whether ketamine-induced antidepressant effect is associated with suppression of NLRP1.Methods Wistar albino rats were divided into control, CUMS, CUMS+acute ketamine (a single 10 mg/kg dose) and CUMS+chronic ketamine (daily 10 mg/kg injections for 3 weeks) groups (n=10 for each group). Sucrose preference test and forced swimming test were performed to assess anhedonia and immobility time respectively for the severety of depression symptoms. Brain tissues were dissected and prefrontal cortex and hippocampus regions were used for real-time polymerase chain reaction (PCR) and immunohistochemical analysis.Results CUMS procedure significantly induced depressive-like symptoms whereas both acute and chronic ketamine treatment ameliorated them. mRNA expression levels of NLRP1, caspase 1, apoptosis-associated speck-like protein containing a CARD (ASC), NF-κB, endothelial nitric oxide synthase, IL-1β, IL-6, toll-like receptor 4 (TLR-4) and purinergic 2×7 receptor (P2X7R) and numbers of Iba- 1+and GFAP+glial cells were reduced by acute and/or chronic ketamine treatment.Conclusion In the present study for the first time upstream and downstream elements of the NLRP1 inflammasome complex are shown to be suppressed by ketamine thus reinforcing the involvement of NLRP1 in the physiopathology of depression.

1 January 2013 in Pharmacology Biochemistry and Behavior
Verified
Journal Article
Closed access
ICIpek Komsuoglu Celikyurt
Ipek Komsuoglu Celikyurt
TUTijen Utkan
Tijen Utkan
SGSemil Selcen Gocmez
Semil Selcen Gocmez
AHAlan Hudson
Alan Hudson
FAFeyza Aricioglu
Feyza Aricioglu